Nevada Code § 585.497

Assessment on gross receipts from sale of amygdalin and procaine hydrochloride
Open in Lexace · Ask the AI about this section
1. An assessment of 10 percent, payable
quarterly to the Department of Taxation, is imposed upon the gross receipts of
a manufacturer from the sale of each substance licensed for manufacture
pursuant to NRS 585.495 .
2. The Nevada Tax Commission shall
prescribe by regulation appropriate forms for reporting such gross receipts,
and shall when appropriate recompute the assessment and collect any deficiency
in the manner provided for taxes required to be paid pursuant to title 32 of
NRS. Each manufacturer shall report the sales and pay the assessment during the
months of January, April, July and October for the respective preceding
calendar quarters.
3. As used in this section:
(a) Gross receipts means the total amount of
the sale of each substance, valued in money, whether received in money or
otherwise, without deduction for any of the following:
(1) The cost of the substance sold.
(2) The cost of the materials used, labor
or service, any interest paid or any losses or other expense.
(3) The cost of marketing the substance.
(4) The cost of transporting the substance
before its sale to the purchaser.
(b) Sale includes any transfer of title or
possession, exchange or barter, whether conditional or otherwise, of a
substance for a consideration.
(c) Total amount of the sale includes:
(1) Any services that are a part of the
sale; and
(2) All receipts, cash, credits and
property of any kind.

‹ Prev All Nevada sections Next ›


Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.